Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-042801
Filing Date
2021-06-23
Accepted
2021-06-23 17:38:14
Documents
1
Period of Report
2021-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 16624
  Complete submission text file 0001209191-21-042801.txt   18018
Mailing Address 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Business Address
NELSEN ROBERT (Reporting) CIK: 0001219042 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40502 | Film No.: 211039603

Mailing Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations